ArticleScientific reports2025
Synergistic transfer learning and adversarial networks for breast cancer diagnosis: benign vs. invasive classification.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Enhanced MobileNet with multi-scale feature fusion for automated breast cancer histopathology classification.Scientific reports · 2026Article
- A comparative analysis of deep learning models for disease classification in multi-organ histopathological images.Scientific reports · 2026Article
- Exploring AI Approaches for Breast Cancer Detection and Diagnosis: A Review Article.Breast cancer (Dove Medical Press) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Current breast cancer diagnosis methods often face limitations such as high cost, time consumption, and inter-observer variability. To address these challenges, this research proposes a novel deep learning framework that leverages generative adversarial networks (GANs) for data augmentation and transfer learning to enhance breast cancer classification using convolutional neural networks (CNNs). The framework uses a two-stage augmentation approach. First, a conditional Wasserstein GAN (cWGAN) generates synthetic breast cancer images based on clinical data, enhancing training stability and enabling targeted feature incorporation. Second, traditional augmentation techniques (e.g., rotation, flipping, cropping) are applied to both original and synthetic images. A multi-scale transfer learning technique is also employed, integrating three pre-trained CNNs (DenseNet-201, NasNetMobile, ResNet-101) with a multi-scale feature enrichment scheme, allowing the model to capture features at various scales. The framework was evaluated on the BreakHis dataset, achieving an accuracy of 99.2% for binary classification and 98.5% for multi-class classification, significantly outperforming existing methods. This framework offers a more efficient, cost-effective, and accurate approach for breast cancer diagnosis. Future work will focus on generalizing the framework to clinical datasets and integrating it into diagnostic workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.